Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Biocatalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103074409A details a novel enzymatic resolution method for high-purity halogenated alpha-amino acids, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106164260B enables high-yield biocatalytic synthesis of (R)-6-hydroxy-8-chlorooctanoate. Discover cost-effective supply chain solutions for lipoic acid precursors.
Patent CN119614528B reveals enhanced hydroxysteroid dehydrogenase mutants for steroid synthesis, offering improved stability and cost reduction in pharmaceutical manufacturing.
Patent CN116536279B reveals novel biocatalytic route for DHEA. Achieves high yield and purity with reduced environmental impact for pharmaceutical supply chains.
Patent CN115433721B details a carbonyl reductase mutant for BHBM synthesis, offering water-based media and superior thermal stability for cost-effective pharma manufacturing.
Patent CN102162002B details an enzymatic route for cyclohexenone derivatives. Mild conditions, high yield, and eco-friendly processing for pharmaceutical intermediates.
Novel feruloyl esterase method reduces solvent use. Efficient aqueous phase synthesis for pharmaceutical intermediates. Supply chain reliability and cost optimization.
Patent CN111363736A reveals a novel enzymatic route for dexketoprofen using Klebsiella amidase, offering superior ee values and greener manufacturing for pharmaceutical intermediates.
Patent CN102719378A reveals high-purity (-)-gamma-lactam production via Delftia sp., offering cost-effective API manufacturing solutions.
Patent CN115786313A reveals a novel nitrilase mutant boosting 2-chloronicotinic acid yield by 23.2 times, offering a green alternative for pharma and agrochemical intermediates.
Patent CN104630241A enables high-purity statin intermediate production with reduced waste and enhanced supply chain reliability for global pharmaceutical manufacturing partners seeking cost efficiency.
Patent CN112625086A reveals a high-purity enzymatic route for Argatroban Impurity G. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN107384982A reveals enzymatic route for Evogliptin. Offers high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN111051506A discloses engineered PGA variants for efficient insulin dimer deprotection. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain advantages.
Novel carbonyl reductase mutants enhance chiral alcohol synthesis yield and stability for pharmaceutical manufacturing supply chains ensuring reliable high-purity intermediate sourcing.
Patent CN113025546A reveals a novel multi-enzyme cascade for tyrosol production, offering significant cost reduction and green manufacturing advantages for pharmaceutical intermediates.
Patent CN119506235A reveals directed evolution for UDCA. Enhances supply chain stability and reduces manufacturing costs significantly.
Patent CN107287256A details a novel whole-cell catalytic method for L-2-piperidinecarboxylic acid, offering high purity and scalable pharmaceutical intermediate manufacturing solutions.
High-purity chiral amine intermediate for levopraziquantel. Enzymatic process ensures cost reduction and supply reliability for pharmaceutical manufacturing.
Patent CN118745205A details a plant-derived ursodeoxycholic acid synthesis avoiding animal risks. Offers high purity and scalable supply chain solutions.